How do peptides work?
How do peptides work? These mechanism articles are the how behind the what. If you want to understand what a GLP-1 dual agonist actually does after injection, why a growth hormone peptide works with your pituitary instead of around it, or which receptor a molecule binds — this is that shelf.
Written to be understood like you're fifteen, sourced from the primary literature, and honest wherever the mechanism is still a hypothesis rather than settled science.
206 articles on this topic
-

TAZPOWER Trial: What the Results Actually Show
TAZPOWER missed its main walking and fatigue goals against placebo. Longer follow-up reported gains, with enough uncertainty to require another trial.
-

1984 Nobel Prize in Chemistry: Making Peptides
Bruce Merrifield’s bead method made peptides easier to build. The breakthrough explains modern synthesis—and why purity testing still matters.
-

Epitalon News Update: October 2026
July brought favorable advisory votes and a new cancer-cell study. Here is what changed for epitalon, what the FDA’s current pages say, and what remains unproven in people.
-

Relative Risk vs Absolute Risk: Numbers Explained
Relative risk compares two groups. Absolute risk shows how often an event happened. SELECT and a gallbladder warning show why both numbers matter.
-

Epitalon for Sleep: Better Sleep Isn't Established
Epitalon has been studied for melatonin production, but better sleep hasn't been demonstrated in people. The small human study measured a hormone marker.
-

MOTS-c Anti Aging: Human Benefits Remain Unproven
MOTS-c has not been shown to slow aging in people. Mouse findings and human blood measurements answer narrower questions about aging.
-

Semaglutide and Smoking: Can It Help You Quit?
Early studies have found lower cigarette cravings, but semaglutide hasn't been established as a quitting treatment. The difference matters when reading the headlines.
-

MMPOWER-3 Trial: Walking and Fatigue Goals Not Met
After 24 weeks, elamipretide did not beat placebo on walking distance or fatigue. A later genetic subgroup finding led to another trial, not a new verdict.
-

Semaglutide and Cholesterol: What Changes?
Semaglutide trials found small cholesterol changes and a larger drop in triglycerides, another blood fat. Those results don’t replace prescribed cholesterol treatment.
-

Semaglutide and Testosterone: What Studies Show
Low testosterone may rise as men with obesity lose weight on semaglutide. Small studies support that link, but a direct hormone effect remains unproven.
-

What Is Bacteriostatic Water? Meaning and Safety
Bacteriostatic water contains a preservative that limits bacterial growth. The medication’s instructions decide whether it is the right mixing liquid.
-

IGF-1 Levels by Age: Reading Your Lab Result
IGF-1 levels by age usually decline after early adulthood. Your lab's range puts the number in context; trial increases aren't treatment targets.
-

Sermorelin Myths: 10 Claims Checked
Sermorelin can stimulate growth-hormone release. Ten familiar claims about aging, muscle, sleep and safety go further than the human studies support.
-

1977 Nobel Prize in Medicine: Peptide Discoveries
Three scientists shared the prize for finding the brain’s hormone messages and making tiny hormone levels measurable. Here’s how that history connects to today’s prescriptions.
-

Who Discovered Ghrelin? Kojima and Kangawa
Masayasu Kojima, Kenji Kangawa and colleagues identified ghrelin in 1999. Earlier peptide and receptor discoveries set up the finding; appetite studies followed.
-

Who Discovered Semax? Its Russian Origins
Igor Ashmarin, Nikolai Myasoedov and a Moscow team developed Semax. Its history runs from modified hormone fragments to Russian registration and U.S. review.
-

Thymosin Alpha 1 News: October 2026 Update
New studies broaden the research questions, while U.S. status remains unchanged. Here is what the July–September quarter adds to a prescribing conversation.
-

What Is Food Noise? Meaning and GLP-1 Evidence
Food noise means intrusive food thoughts that are hard to set aside. GLP-1 studies offer evidence about cravings and eating control, while the term itself is still being defined.
-

Zenagamtide: Amycretin’s New Name, Still in Trials
Zenagamtide is amycretin’s new name: an experimental drug being tested as a weekly shot and a daily pill. Here’s what the trials actually found.
-

Epitalon Telomeres: What the Studies Actually Show
The claim comes from cells studied outside the body. Those findings haven't established a longer or healthier life for people taking epitalon.
Page 1 of 11 · 206 articles